- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Transcend Therapeutics Patents
Transcend Therapeutics has filed 1 patent.
The 3 most popular patent topics include:
- Amines
- Designer drugs
- Entactogens and empathogens
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/15/2022 | 7/25/2023 | Designer drugs, Stimulants, Substituted amphetamines, Entactogens and empathogens, Amines | Grant |
Application Date | 8/15/2022 |
|---|---|
Grant Date | 7/25/2023 |
Title | |
Related Topics | Designer drugs, Stimulants, Substituted amphetamines, Entactogens and empathogens, Amines |
Status | Grant |
Latest Transcend Therapeutics News
Mar 5, 2023
GV led Chroma Medicines Series B financing round, which the biotech will apply toward epigenetic medicines that could offer advantages over other editing technologies. Other recent financings include rounds from Cargo Therapeutics and Transcend Therapeutics.
Transcend Therapeutics Frequently Asked Questions (FAQ)
Where is Transcend Therapeutics's headquarters?
Transcend Therapeutics's headquarters is located at Cambridge.
What is Transcend Therapeutics's latest funding round?
Transcend Therapeutics's latest funding round is Series D - II.
How much did Transcend Therapeutics raise?
Transcend Therapeutics raised a total of $3.08M.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
